Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region

Robert Mabry, Mridula Rani, Robert Geiger, Gene B. Hubbard, Ricardo Carrion, Kathleen Brasky, Jean L. Patterson, George Georgiou, B. L. Iverson

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Passive immunization has been successfully employed for protection against bacterial and viral infections For over 100 years. Immunoglobulin Fc regions play a critical role in the clearance of bacterial pathogens by mediating antibody-dependent and complement-dependent cytotoxicity. Here we show that antibody fragments engineered to recognize the protective antigen component of the B. anthracis exotoxin with high affinity and conjugated to polyethylene glycol (PEG) for prolonged circulation half-life confer significant protection against inhalation anthrax despite their lack of Fc regions. The speed and lower manufacturing cost of bacterially expressed PEGylated antibody fragments could provide decisive advantages for anthrax prophylaxis. Importantly, our results suggest that PEGylated antibody fragments may represent a unique approach for mounting a rapid therapeutic response to emerging pathogen infections.

Original languageEnglish (US)
Pages (from-to)8362-8368
Number of pages7
JournalInfection and Immunity
Volume73
Issue number12
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Antitoxins
Anthrax
Immunoglobulin Fragments
Immunoglobulin Fc Fragments
Exotoxins
Passive Immunization
Virus Diseases
Bacterial Infections
Half-Life
Antigens
Costs and Cost Analysis
Antibodies
Infection
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Mabry, R., Rani, M., Geiger, R., Hubbard, G. B., Carrion, R., Brasky, K., ... Iverson, B. L. (2005). Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infection and Immunity, 73(12), 8362-8368. https://doi.org/10.1128/IAI.73.12.8362-8368.2005

Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. / Mabry, Robert; Rani, Mridula; Geiger, Robert; Hubbard, Gene B.; Carrion, Ricardo; Brasky, Kathleen; Patterson, Jean L.; Georgiou, George; Iverson, B. L.

In: Infection and Immunity, Vol. 73, No. 12, 12.2005, p. 8362-8368.

Research output: Contribution to journalArticle

Mabry, R, Rani, M, Geiger, R, Hubbard, GB, Carrion, R, Brasky, K, Patterson, JL, Georgiou, G & Iverson, BL 2005, 'Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region', Infection and Immunity, vol. 73, no. 12, pp. 8362-8368. https://doi.org/10.1128/IAI.73.12.8362-8368.2005
Mabry, Robert ; Rani, Mridula ; Geiger, Robert ; Hubbard, Gene B. ; Carrion, Ricardo ; Brasky, Kathleen ; Patterson, Jean L. ; Georgiou, George ; Iverson, B. L. / Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. In: Infection and Immunity. 2005 ; Vol. 73, No. 12. pp. 8362-8368.
@article{7d35d72126f043528b7a1fddc2ce0fa1,
title = "Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region",
abstract = "Passive immunization has been successfully employed for protection against bacterial and viral infections For over 100 years. Immunoglobulin Fc regions play a critical role in the clearance of bacterial pathogens by mediating antibody-dependent and complement-dependent cytotoxicity. Here we show that antibody fragments engineered to recognize the protective antigen component of the B. anthracis exotoxin with high affinity and conjugated to polyethylene glycol (PEG) for prolonged circulation half-life confer significant protection against inhalation anthrax despite their lack of Fc regions. The speed and lower manufacturing cost of bacterially expressed PEGylated antibody fragments could provide decisive advantages for anthrax prophylaxis. Importantly, our results suggest that PEGylated antibody fragments may represent a unique approach for mounting a rapid therapeutic response to emerging pathogen infections.",
author = "Robert Mabry and Mridula Rani and Robert Geiger and Hubbard, {Gene B.} and Ricardo Carrion and Kathleen Brasky and Patterson, {Jean L.} and George Georgiou and Iverson, {B. L.}",
year = "2005",
month = "12",
doi = "10.1128/IAI.73.12.8362-8368.2005",
language = "English (US)",
volume = "73",
pages = "8362--8368",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region

AU - Mabry, Robert

AU - Rani, Mridula

AU - Geiger, Robert

AU - Hubbard, Gene B.

AU - Carrion, Ricardo

AU - Brasky, Kathleen

AU - Patterson, Jean L.

AU - Georgiou, George

AU - Iverson, B. L.

PY - 2005/12

Y1 - 2005/12

N2 - Passive immunization has been successfully employed for protection against bacterial and viral infections For over 100 years. Immunoglobulin Fc regions play a critical role in the clearance of bacterial pathogens by mediating antibody-dependent and complement-dependent cytotoxicity. Here we show that antibody fragments engineered to recognize the protective antigen component of the B. anthracis exotoxin with high affinity and conjugated to polyethylene glycol (PEG) for prolonged circulation half-life confer significant protection against inhalation anthrax despite their lack of Fc regions. The speed and lower manufacturing cost of bacterially expressed PEGylated antibody fragments could provide decisive advantages for anthrax prophylaxis. Importantly, our results suggest that PEGylated antibody fragments may represent a unique approach for mounting a rapid therapeutic response to emerging pathogen infections.

AB - Passive immunization has been successfully employed for protection against bacterial and viral infections For over 100 years. Immunoglobulin Fc regions play a critical role in the clearance of bacterial pathogens by mediating antibody-dependent and complement-dependent cytotoxicity. Here we show that antibody fragments engineered to recognize the protective antigen component of the B. anthracis exotoxin with high affinity and conjugated to polyethylene glycol (PEG) for prolonged circulation half-life confer significant protection against inhalation anthrax despite their lack of Fc regions. The speed and lower manufacturing cost of bacterially expressed PEGylated antibody fragments could provide decisive advantages for anthrax prophylaxis. Importantly, our results suggest that PEGylated antibody fragments may represent a unique approach for mounting a rapid therapeutic response to emerging pathogen infections.

UR - http://www.scopus.com/inward/record.url?scp=28444435513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28444435513&partnerID=8YFLogxK

U2 - 10.1128/IAI.73.12.8362-8368.2005

DO - 10.1128/IAI.73.12.8362-8368.2005

M3 - Article

C2 - 16299334

AN - SCOPUS:28444435513

VL - 73

SP - 8362

EP - 8368

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 12

ER -